Format

Send to

Choose Destination
Expert Opin Ther Pat. 2018 Feb;28(2):93-110. doi: 10.1080/13543776.2018.1406478. Epub 2017 Dec 5.

Serine protease inhibitors to treat inflammation: a patent review (2011-2016).

Author information

1
a B2A, Biological Adaptation and Ageing, Integrated Cellular Ageing and Inflammation, Molecular & Functional Enzymology , Sorbonne Universit├ęs , UPMC Univ Paris 06, UMR 8256 , Paris , France.

Abstract

Inflammation is a physiological part of the complex biological response of tissues to counteract various harmful signals. This process involves diverse actors such as immune cells, blood vessels, and nerves as sources of mediators for inflammation control. Among them serine proteases are key elements in both physiological and pathological inflammation. Areas covered: Serine protease inhibitors to treat inflammatory diseases are being actively investigated by various industrial and academic institutions. The present review covers patent literature on serine protease inhibitors for the therapy of inflammatory diseases patented between 2011 and 2016. Expert opinion: Serine proteases regulating inflammation are versatile enzymes, usually involved in proinflammatory cytokine production and activation of immune cells. Their dysregulation during inflammation can have devastating consequences, promoting various diseases including skin and lung inflammation, neuroinflammation, and inflammatory arthritis. Several serine proteases were selected for their contribution to inflammatory diseases and significant efforts that are spread to develop inhibitors. Strategies developed for inhibitor identification consist on either peptide-based inhibitor derived from endogenous protein inhibitors or small-organic molecules. It is also worth noting that among the recent patents on serine protease inhibitors related to inflammation a significant number are related to retinal vascular dysfunction and skin diseases.

KEYWORDS:

Serine proteases; gastrointestinal inflammation; inflammation; kallikreins; lung inflammation; neutrophil elastase; plasmin; skin inflammation; therapeutical inhibitors

PMID:
29171765
DOI:
10.1080/13543776.2018.1406478
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center